Heart Failure Perspective

 
 
  • Top News From TCT 2018: Slideshow TCT 2018 provided "very impactful" results on MitraClip, promising data on new and novel stents, and data on the newly-identified problem of patient-prosthesis mismatch in TAVR.
  • Teaming Up to Prevent Heart Disease in People With Diabetes   The American Heart Association and American Diabetes Association are collaborating to improve cardiovascular care of patients with diabetes. Drs Ileana Piña and Stacey Rosen discuss the initiative.
  • Time Out! A Close Look at Antibiotic Use in LTC Clinical cases illustrate the overuse of antibiotics to treat radiographic findings and lab reports, especially when prescribing over the phone.
  • Diabetes Care in Older Adults With CVD: Expert Analysis Glycemic control can be challenging in older patients with co-existing CVD and diabetes. Learn optimal management strategies from experts at ACC.
  • Banish These Five Terms From Medicine? A clinician's word choice can significantly influence a patient's medical decisions. Here are five words that many clinicians are trying to remove from their medical vocabularies.
  • TCT 2018COAPT Hits Sweet Spot of MitraClip Efficacy for Secondary MR   The trial drew applause at TCT but the findings contrast with those of MITRA-FR. What does this mean for the percutaneous management of secondary mitral regurgitation in patients with heart failure?
  • Coronary Microvascular Dysfunction: Common Finding in HFpEF   Dr Ileana Piña discusses coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction with PROMIS-HFpEF investigator Dr Carolyn Lam.
  • TCT 2018Clinician-Scientists: Impartiality Co-opted? Why do positive clinical trials draw applause while neutral studies are seen as disappointing? Shouldn't impartial scientists embrace all findings equally?
  • TCT 2018MitraClip for Secondary MR -- The Redux Two conflicting studies on the percutaneous treatment of secondary mitral regurgitation in patients with heart failure lead John Mandrola, MD, to compare and contrast as we await the tiebreaker third.
  • COMMANDER HF: What Now for Anticoagulation in Heart Failure?   Drs Ileana Piña and Mandeep Mehra discuss the neutral results of the COMMANDER HF trial on rivaroxaban in patients with heart failure in sinus rhythm.
  • A 52-Year-Old Man With Dyspnea: USMLE Question A 52-year-old man presents with progressive dyspnea and purulent sputum production. What's the most likely diagnosis?
  • Beta-Blockade After MI: No Practice Should Be Set in Stone Meta-analyses suggest little benefit for beta-blockers in contemporary patients with normal ejection fraction after MI. What other dogma should be revisited in light of an evolving evidence base?
  • Top News From ESC 2018: Slideshow Headlines from the world's largest cardiology meeting include surprising negative trials of fish oil supplements and aspirin for cardiovascular prevention.
  • ESC 2018Don't Ignore the Many Lessons of the MitraClip Failure Reflecting on the MITRA-FR trial, Dr John Mandrola says it can help us learn both specific lessons about the treatment of people with heart failure and more general lessons on the acceptance of untested therapeutics.
  • ESC 2018Do Cardiologists Care About CV Prevention? Everyone agrees that prevention is better than cure. However, few ESC attendees joined Melissa Walton-Shirley for the session on CVD prevention, preferring to stand in line to hear the latest hotlines.
  • ESC 2018Cardiology 2028: Predicting the Future Melissa Walton-Shirley attended a session at the European Society of Cardiology Congress titled "Cardiology 10 Years From Now" and heard some realistic predictions.
  • ESC 2018Overprescribing in the Elderly: We Have a Problem Melissa Walton-Shirley sat in on a presentation about polypharmacy in older patients and learned some surprising statistics.
  • Improving Organ Yield With Advanced Hemodynamic Monitoring Transplant teams and organ procurement organizations adopt newer technologies to guide donor management, improve organ function, and increase the number of life-saving organs available for transplant.
  • K2/Spice Contamination: What MDs Need to Know   As more patients overdose on synthetic cannabinoids laced with contaminants, toxicologists review what is critical in treatment and what hospitals need to do to be prepared.
  • For Better Clinical Research, Collaborate With Statisticians   Volunteering at a VA hospital was the first step in biostatistician Frank Harrell's illustrious career in cardiovascular research.